Author: Cantor L.B.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.10, Iss.4, 2001-04, pp. : 721-731
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
An update on bimatoprost in glaucoma therapy
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. :
Bimatoprost/timolol of value for glaucoma in Europe
Inpharma, Vol. 1, Iss. 1634, 2008-01 ,pp. :
Bimatoprost best value for glaucoma in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 500, 2006-01 ,pp. :
Bimatoprost/timolol of value for glaucoma in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 551, 2008-01 ,pp. :
Bimatoprost best bet for glaucoma in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. :